Kyntra Bio KYNB
NASDAQ KYNB
$7.52 +0.20 (+2.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Enterprise Value Growth (5y) (2019 - 2026)

Kyntra Bio (KYNB) Enterprise Value Growth (5y) (2019 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Kyntra Bio 30.42 Mn 30.42 Mn 1.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 32.21%
Mar 31, 2026 50.55%
Dec 31, 2025 44.11%
Sep 30, 2025 58.37%
Jun 30, 2025 57.05%
Mar 31, 2025 15.16%
Dec 31, 2024 30.96%
Sep 30, 2024 29.05%
Jun 30, 2024 -16.60%
Mar 31, 2024 -8.01%
Dec 31, 2023 18.68%
Sep 30, 2023 5.47%
Jun 30, 2023 13.60%
Mar 31, 2023 13.27%
Dec 31, 2022 8.40%
Sep 30, 2022 11.38%
Jun 30, 2022 -4.22%
Mar 31, 2022 -12.73%
Dec 31, 2021 -10.49%
Sep 30, 2021 -15.99%